News

Recent Articles

Immunovaccine Initiates Clinical Trial with DPX-RSV Vaccine

Halifax, Nova Scotia; June 30, 2015 – Immunovaccine Inc. , a clinical stage vaccine and immunotherapy company, today announced that it has enrolled the first healthy adult volunteer in a Phase 1 clinical study of its respiratory syncytial virus (RSV) vaccine. The Phase 1 study will evaluate the safety and immune response profile of the… Read More»

Posted on July 9, 2015
Newer»